These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 1803412)
21. Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids. Morrill JC; Mebus CA; Peters CJ Am J Vet Res; 1997 Oct; 58(10):1110-4. PubMed ID: 9328663 [TBL] [Abstract][Full Text] [Related]
22. The synergistic neutralization of Rift Valley fever virus by monoclonal antibodies to the envelope glycoproteins. Besselaar TG; Blackburn NK Arch Virol; 1992; 125(1-4):239-50. PubMed ID: 1642552 [TBL] [Abstract][Full Text] [Related]
23. Genetic variation among geographic isolates of Rift Valley fever virus. Battles JK; Dalrymple JM Am J Trop Med Hyg; 1988 Dec; 39(6):617-31. PubMed ID: 2462795 [TBL] [Abstract][Full Text] [Related]
24. Serological evidence of inter-epizootic/inter-epidemic circulation of Rift Valley fever virus in domestic cattle in Kyela and Morogoro, Tanzania. Matiko MK; Salekwa LP; Kasanga CJ; Kimera SI; Evander M; Nyangi WP PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006931. PubMed ID: 30418975 [TBL] [Abstract][Full Text] [Related]
25. Production of monoclonal antibodies against Rift Valley fever virus Application for rapid diagnosis tests (virus detection and ELISA) in human sera. Zaki A; Coudrier D; Yousef AI; Fakeeh M; Bouloy M; Billecocq A J Virol Methods; 2006 Jan; 131(1):34-40. PubMed ID: 16102851 [TBL] [Abstract][Full Text] [Related]
26. [Epidemiology of Rift Valley fever in west Africa. 1. Serological investigation of small ruminants in Niger]. Akakpo AJ; Saluzzo JF; Bada R; Bornarel P; Sarradin P Bull Soc Pathol Exot; 1991; 84(3):217-24. PubMed ID: 1764749 [TBL] [Abstract][Full Text] [Related]
27. Experimental infection and protection of lambs with a minute plaque variant of Rift Valley fever virus. Moussa MI; Abdel-Wahab KS; Wood OL Am J Trop Med Hyg; 1986 May; 35(3):660-2. PubMed ID: 3706629 [TBL] [Abstract][Full Text] [Related]
28. Rift Valley fever vaccines: an overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate. Ikegami T Expert Rev Vaccines; 2017 Jun; 16(6):601-611. PubMed ID: 28425834 [TBL] [Abstract][Full Text] [Related]
29. [Rift Valley Fever and phleboviroses in the Central African Republic]. Meunier DM; Madelon MC; Lesbordes JL; Georges AJ Bull Soc Pathol Exot Filiales; 1988; 81(1):49-57. PubMed ID: 3042177 [TBL] [Abstract][Full Text] [Related]
30. Molecular and serological studies on the Rift Valley fever outbreak in Mauritania in 2010. Jäckel S; Eiden M; El Mamy BO; Isselmou K; Vina-Rodriguez A; Doumbia B; Groschup MH Transbound Emerg Dis; 2013 Nov; 60 Suppl 2():31-9. PubMed ID: 24589099 [TBL] [Abstract][Full Text] [Related]
32. Indirect enzyme-linked immunosorbent assay for the detection of antibody against Rift Valley fever virus in domestic and wild ruminant sera. Paweska JT; Smith SJ; Wright IM; Williams R; Cohen AS; Van Dijk AA; Grobbelaar AA; Croft JE; Swanepoel R; Gerdes GH Onderstepoort J Vet Res; 2003 Mar; 70(1):49-64. PubMed ID: 12825681 [TBL] [Abstract][Full Text] [Related]
33. Development and characterization of monoclonal antibodies against Rift Valley fever virus nucleocapsid protein generated by DNA immunization. Martín-Folgar R; Lorenzo G; Boshra H; Iglesias J; Mateos F; Borrego B; Brun A MAbs; 2010; 2(3):275-84. PubMed ID: 20400862 [TBL] [Abstract][Full Text] [Related]
34. Comparison of enzyme-linked immunosorbent assay systems using rift valley fever virus nucleocapsid protein and inactivated virus as antigens. Yu F; Adungo F; Konongoi SL; Inoue S; Sang R; Ashur S; Kwallah AO; Uchida L; Buerano CC; Mwau M; Zha Y; Nie Y; Morita K Virol J; 2018 Nov; 15(1):178. PubMed ID: 30466469 [TBL] [Abstract][Full Text] [Related]
35. The use of sucrose-acetone-extracted Rift Valley fever virus antigen derived from cell culture in an indirect enzyme-linked immunosorbent assay and haemagglutination-inhibition test. Paweska JT; Barnard BJ; Williams R Onderstepoort J Vet Res; 1995 Dec; 62(4):227-33. PubMed ID: 8668320 [TBL] [Abstract][Full Text] [Related]
36. Attenuation and protective efficacy of Rift Valley fever phlebovirus rMP12-GM50 strain. Ly HJ; Nishiyama S; Lokugamage N; Smith JK; Zhang L; Perez D; Juelich TL; Freiberg AN; Ikegami T Vaccine; 2017 Dec; 35(48 Pt B):6634-6642. PubMed ID: 29061350 [TBL] [Abstract][Full Text] [Related]
37. Preliminary evaluation of diagnostic accuracy and precision of a competitive ELISA for detection of antibodies to Rift Valley fever virus in cattle and sheep sera. Upreti D; Cernicchiaro N; Richt JA; Wilson WC; Clavijo A; Davis AS J Virol Methods; 2018 Dec; 262():6-11. PubMed ID: 30205125 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of the Efficacy, Potential for Vector Transmission, and Duration of Immunity of MP-12, an Attenuated Rift Valley Fever Virus Vaccine Candidate, in Sheep. Miller MM; Bennett KE; Drolet BS; Lindsay R; Mecham JO; Reeves WK; Weingartl HM; Wilson WC Clin Vaccine Immunol; 2015 Aug; 22(8):930-7. PubMed ID: 26041042 [TBL] [Abstract][Full Text] [Related]
39. Development of a Quantitative RT-PCR Assay to Differentiate Rift Valley Fever Virus Smithburn Vaccine Strain from Clone 13 Vaccine Strain. Kim HJ; Lyoo HR; Choi JS; Lee YH; Kim BH; Yoo HS Vector Borne Zoonotic Dis; 2019 Feb; 19(2):121-127. PubMed ID: 30300113 [TBL] [Abstract][Full Text] [Related]
40. Seroprevalence of Rift Valley fever and lumpy skin disease in African buffalo (Syncerus caffer) in the Kruger National Park and Hluhluwe-iMfolozi Park, South Africa. Fagbo S; Coetzer JA; Venter EH J S Afr Vet Assoc; 2014 Oct; 85(1):e1-e7. PubMed ID: 25686252 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]